Logo image of HSII

HEIDRICK & STRUGGLES INTL (HSII) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HSII - US4228191023 - Common Stock

59.01 USD
+0.04 (+0.07%)
Last: 12/9/2025, 8:05:31 PM
59.01 USD
0 (0%)
After Hours: 12/9/2025, 8:05:31 PM
Fundamental Rating

5

Overall HSII gets a fundamental rating of 5 out of 10. We evaluated HSII against 87 industry peers in the Professional Services industry. Both the profitability and the financial health of HSII get a neutral evaluation. Nothing too spectacular is happening here. HSII has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HSII had positive earnings in the past year.
HSII had a positive operating cash flow in the past year.
Of the past 5 years HSII 4 years were profitable.
Of the past 5 years HSII 4 years had a positive operating cash flow.
HSII Yearly Net Income VS EBIT VS OCF VS FCFHSII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

The Return On Assets of HSII (2.93%) is comparable to the rest of the industry.
HSII has a Return On Equity (7.28%) which is comparable to the rest of the industry.
The Return On Invested Capital of HSII (8.74%) is better than 60.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HSII is in line with the industry average of 12.13%.
Industry RankSector Rank
ROA 2.93%
ROE 7.28%
ROIC 8.74%
ROA(3y)4.09%
ROA(5y)2.81%
ROE(3y)11.02%
ROE(5y)8.12%
ROIC(3y)10.87%
ROIC(5y)11.02%
HSII Yearly ROA, ROE, ROICHSII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

HSII has a Profit Margin of 3.04%. This is comparable to the rest of the industry: HSII outperforms 54.02% of its industry peers.
In the last couple of years the Profit Margin of HSII has declined.
HSII has a Operating Margin (6.59%) which is in line with its industry peers.
In the last couple of years the Operating Margin of HSII has declined.
HSII's Gross Margin of 87.57% is amongst the best of the industry. HSII outperforms 95.40% of its industry peers.
HSII's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.59%
PM (TTM) 3.04%
GM 87.57%
OM growth 3Y-13.17%
OM growth 5Y-6.58%
PM growth 3Y-52.28%
PM growth 5Y-34.45%
GM growth 3Y-2.32%
GM growth 5Y-2.06%
HSII Yearly Profit, Operating, Gross MarginsHSII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HSII is still creating some value.
HSII has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HSII has been increased compared to 5 years ago.
There is no outstanding debt for HSII. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HSII Yearly Shares OutstandingHSII Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HSII Yearly Total Debt VS Total AssetsHSII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

HSII has an Altman-Z score of 2.69. This is not the best score and indicates that HSII is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.69, HSII is in line with its industry, outperforming 48.28% of the companies in the same industry.
There is no outstanding debt for HSII. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.69
ROIC/WACC0.99
WACC8.82%
HSII Yearly LT Debt VS Equity VS FCFHSII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.53 indicates that HSII should not have too much problems paying its short term obligations.
HSII has a Current ratio (1.53) which is comparable to the rest of the industry.
HSII has a Quick Ratio of 1.53. This is a normal value and indicates that HSII is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of HSII (1.53) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
HSII Yearly Current Assets VS Current LiabilitesHSII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.38% over the past year.
The Earnings Per Share has been growing slightly by 3.93% on average over the past years.
HSII shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.53%.
The Revenue has been growing by 8.99% on average over the past years. This is quite good.
EPS 1Y (TTM)23.38%
EPS 3Y-7.75%
EPS 5Y3.93%
EPS Q2Q%15.28%
Revenue 1Y (TTM)11.53%
Revenue growth 3Y3.42%
Revenue growth 5Y8.99%
Sales Q2Q%15.94%

3.2 Future

HSII is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.57% yearly.
The Revenue is expected to grow by 6.49% on average over the next years.
EPS Next Y-0.27%
EPS Next 2Y6.55%
EPS Next 3Y9.57%
EPS Next 5YN/A
Revenue Next Year12.64%
Revenue Next 2Y5.79%
Revenue Next 3Y6.49%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSII Yearly Revenue VS EstimatesHSII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
HSII Yearly EPS VS EstimatesHSII Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.20, HSII is valued on the expensive side.
Based on the Price/Earnings ratio, HSII is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
HSII is valuated rather cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.55, the valuation of HSII can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as HSII.
HSII is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.2
Fwd PE 16.55
HSII Price Earnings VS Forward Price EarningsHSII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HSII is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSII indicates a rather cheap valuation: HSII is cheaper than 88.51% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.26
EV/EBITDA 6.21
HSII Per share dataHSII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.38
EPS Next 2Y6.55%
EPS Next 3Y9.57%

6

5. Dividend

5.1 Amount

HSII has a Yearly Dividend Yield of 1.02%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.12, HSII pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.02, HSII pays less dividend than the S&P500 average, which is at 2.31.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

The dividend of HSII has a limited annual growth rate of 0.64%.
HSII has paid a dividend for at least 10 years, which is a reliable track record.
HSII has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.64%
Div Incr Years0
Div Non Decr Years11
HSII Yearly Dividends per shareHSII Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

HSII pays out 35.14% of its income as dividend. This is a sustainable payout ratio.
The dividend of HSII is growing, but earnings are growing more, so the dividend growth is sustainable.
DP35.14%
EPS Next 2Y6.55%
EPS Next 3Y9.57%
HSII Yearly Income VS Free CF VS DividendHSII Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
HSII Dividend Payout.HSII Dividend Payout, showing the Payout Ratio.HSII Dividend Payout.PayoutRetained Earnings

HEIDRICK & STRUGGLES INTL

NASDAQ:HSII (12/9/2025, 8:05:31 PM)

After market: 59.01 0 (0%)

59.01

+0.04 (+0.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)03-02 2026-03-02/amc
Inst Owners97.04%
Inst Owner Change0.09%
Ins Owners1.02%
Ins Owner Change0.09%
Market Cap1.23B
Revenue(TTM)1.22B
Net Income(TTM)37.05M
Analysts45.71
Price Target60.18 (1.98%)
Short Float %2.53%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0.64
Dividend Growth(5Y)0.64%
DP35.14%
Div Incr Years0
Div Non Decr Years11
Ex-Date11-13 2025-11-13 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.1%
Min EPS beat(2)7.07%
Max EPS beat(2)13.12%
EPS beat(4)3
Avg EPS beat(4)21.68%
Min EPS beat(4)-2.45%
Max EPS beat(4)68.96%
EPS beat(8)7
Avg EPS beat(8)15.42%
EPS beat(12)10
Avg EPS beat(12)13.71%
EPS beat(16)13
Avg EPS beat(16)13.68%
Revenue beat(2)2
Avg Revenue beat(2)5.17%
Min Revenue beat(2)4.75%
Max Revenue beat(2)5.59%
Revenue beat(4)4
Avg Revenue beat(4)4.94%
Min Revenue beat(4)4.61%
Max Revenue beat(4)5.59%
Revenue beat(8)8
Avg Revenue beat(8)3.68%
Revenue beat(12)11
Avg Revenue beat(12)2.99%
Revenue beat(16)13
Avg Revenue beat(16)2.7%
PT rev (1m)0%
PT rev (3m)10.63%
EPS NQ rev (1m)-3.57%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.68%
EPS NY rev (3m)6.23%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)1.96%
Revenue NY rev (3m)2.04%
Valuation
Industry RankSector Rank
PE 17.2
Fwd PE 16.55
P/S 1.01
P/FCF 9.26
P/OCF 7.61
P/B 2.41
P/tB 3.43
EV/EBITDA 6.21
EPS(TTM)3.43
EY5.81%
EPS(NY)3.56
Fwd EY6.04%
FCF(TTM)6.37
FCFY10.8%
OCF(TTM)7.76
OCFY13.14%
SpS58.59
BVpS24.49
TBVpS17.21
PEG (NY)N/A
PEG (5Y)4.38
Graham Number43.48
Profitability
Industry RankSector Rank
ROA 2.93%
ROE 7.28%
ROCE 11.06%
ROIC 8.74%
ROICexc 32.14%
ROICexgc 138.41%
OM 6.59%
PM (TTM) 3.04%
GM 87.57%
FCFM 10.87%
ROA(3y)4.09%
ROA(5y)2.81%
ROE(3y)11.02%
ROE(5y)8.12%
ROIC(3y)10.87%
ROIC(5y)11.02%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.76%
ROCE(5y)13.95%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-49.09%
ROICexc growth 5Y4.22%
OM growth 3Y-13.17%
OM growth 5Y-6.58%
PM growth 3Y-52.28%
PM growth 5Y-34.45%
GM growth 3Y-2.32%
GM growth 5Y-2.06%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 140.86%
Cap/Sales 2.37%
Interest Coverage 250
Cash Conversion 160.16%
Profit Quality 357.48%
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 2.69
F-Score5
WACC8.82%
ROIC/WACC0.99
Cap/Depr(3y)105.62%
Cap/Depr(5y)75.16%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.38%
EPS 3Y-7.75%
EPS 5Y3.93%
EPS Q2Q%15.28%
EPS Next Y-0.27%
EPS Next 2Y6.55%
EPS Next 3Y9.57%
EPS Next 5YN/A
Revenue 1Y (TTM)11.53%
Revenue growth 3Y3.42%
Revenue growth 5Y8.99%
Sales Q2Q%15.94%
Revenue Next Year12.64%
Revenue Next 2Y5.79%
Revenue Next 3Y6.49%
Revenue Next 5YN/A
EBIT growth 1Y5.29%
EBIT growth 3Y-10.2%
EBIT growth 5Y1.81%
EBIT Next Year100.42%
EBIT Next 3Y31.85%
EBIT Next 5YN/A
FCF growth 1Y503.79%
FCF growth 3Y-22.36%
FCF growth 5Y10.54%
OCF growth 1Y894.35%
OCF growth 3Y-17.86%
OCF growth 5Y13.86%

HEIDRICK & STRUGGLES INTL / HSII FAQ

What is the fundamental rating for HSII stock?

ChartMill assigns a fundamental rating of 5 / 10 to HSII.


What is the valuation status for HSII stock?

ChartMill assigns a valuation rating of 5 / 10 to HEIDRICK & STRUGGLES INTL (HSII). This can be considered as Fairly Valued.


What is the profitability of HSII stock?

HEIDRICK & STRUGGLES INTL (HSII) has a profitability rating of 4 / 10.


Can you provide the financial health for HSII stock?

The financial health rating of HEIDRICK & STRUGGLES INTL (HSII) is 6 / 10.


Can you provide the expected EPS growth for HSII stock?

The Earnings per Share (EPS) of HEIDRICK & STRUGGLES INTL (HSII) is expected to decline by -0.27% in the next year.